<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36284339</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-9158</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>26</Day></PubDate></JournalIssue><Title>Translational neurodegeneration</Title><ISOAbbreviation>Transl Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Association of variants in the KIF1A gene with amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>46</StartPage><MedlinePgn>46</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">46</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-022-00320-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is a devastating progressive neurodegenerative disease that affects neurons in the central nervous system and the spinal cord. As in many other neurodegenerative disorders, the genetic risk factors and pathogenesis of ALS involve dysregulation of cytoskeleton and neuronal transport. Notably, sensory and motor neuron diseases such as hereditary sensory and autonomic neuropathy type 2 (HSAN2) and spastic paraplegia 30 (SPG30) share several causative genes with ALS, as well as having common clinical phenotypes. KIF1A encodes a kinesin 3 motor that transports presynaptic vesicle precursors (SVPs) and dense core vesicles and has been reported as a causative gene for HSAN2 and SPG30.</AbstractText><AbstractText Label="METHODS">Here, we analyzed whole-exome sequencing data from 941 patients with ALS to investigate the genetic association of KIF1A with ALS.</AbstractText><AbstractText Label="RESULTS">We identified rare damage variants (RDVs) in the KIF1A gene associated with ALS and delineated the clinical characteristics of ALS patients with KIF1A RDVs. Clinically, these patients tended to exhibit sensory disturbance. Interestingly, the majority of these variants are located at the C-terminal cargo-binding region of the KIF1A protein. Functional examination revealed that the ALS-associated KIF1A variants located in the C-terminal region preferentially enhanced the binding of SVPs containing RAB3A, VAMP2, and synaptophysin. Expression of several disease-related KIF1A mutants in cultured mouse cortical neurons led to enhanced colocalization of RAB3A or VAMP2 with the KIF1A motor.</AbstractText><AbstractText Label="CONCLUSIONS">Our study highlighted the importance of KIF1A motor-mediated transport in the pathogenesis of ALS, indicating KIF1A as an important player in the oligogenic scenario of ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liao</LastName><ForeName>Panlin</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hunan Key Laboratory of Molecular Precision Medicine, Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yuan</LastName><ForeName>Yanchun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Xiaorong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wanzhen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hunan Key Laboratory of Molecular Precision Medicine, Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kexuan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Hunan Key Laboratory of Molecular Precision Medicine, Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jifeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Beisha</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhuohua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Hunan Key Laboratory of Molecular Precision Medicine, Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Zhonghua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Hunan Key Laboratory of Molecular Precision Medicine, Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China. huzhonghua@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China. huzhonghua@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, China. huzhonghua@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Provincial Clinical Research Center for Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China. huzhonghua@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Sciences, Central South University, Changsha, 410008, China. huzhonghua@csu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Junling</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5117-5204</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China. junling.wang@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China. junling.wang@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, 410008, China. junling.wang@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, China. junling.wang@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Engineering Research Center of Hunan Province in Cognitive Impairment Disorders, Central South University, Changsha, 410008, China. junling.wang@csu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, 410008, China. junling.wang@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transl Neurodegener</MedlineTA><NlmUniqueID>101591861</NlmUniqueID><ISSNLinking>2047-9158</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.4.4</RegistryNumber><NameOfSubstance UI="D016547">Kinesins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016708">Synaptophysin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050988">Vesicle-Associated Membrane Protein 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C490576">Kif1a protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016547" MajorTopicYN="N">Kinesins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016708" MajorTopicYN="N">Synaptophysin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050988" MajorTopicYN="N">Vesicle-Associated Membrane Protein 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015419" MajorTopicYN="Y">Spastic Paraplegia, Hereditary</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009477" MajorTopicYN="Y">Hereditary Sensory and Autonomic Neuropathies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Axonal transport</Keyword><Keyword MajorTopicYN="N">KIF1A</Keyword><Keyword MajorTopicYN="N">Presynaptic vesicle precursors</Keyword></KeywordList><CoiStatement>The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36284339</ArticleId><ArticleId IdType="pmc">PMC9597953</ArticleId><ArticleId IdType="doi">10.1186/s40035-022-00320-2</ArticleId><ArticleId IdType="pii">10.1186/s40035-022-00320-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Yuan Y, Wang M, Ni J, Li W, Huang L, et al. Mutation spectrum of amyotrophic lateral sclerosis in Central South China. Neurobiol Aging. 2021;107:181&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">34275688</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chi&#xf2; A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17(1):94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B, Horton DK, Mitsumoto H. Potential environmental factors in amyotrophic lateral sclerosis. Neurol Clin. 2015;33(4):877&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646848</ArticleId><ArticleId IdType="pubmed">26515627</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol. 2016;138:225&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellanos-Montiel MJ, Chaineau M, Durcan TM. The neglected genes of ALS: cytoskeletal dynamics impact synaptic degeneration in ALS. Front Cell Neurosci. 2020;14:594975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7691654</ArticleId><ArticleId IdType="pubmed">33281562</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N, Akiyama T, Warita H, Aoki M. Omics approach to axonal dysfunction of motor neurons in amyotrophic lateral sclerosis (ALS) Front Neurosci. 2020;14:194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7109447</ArticleId><ArticleId IdType="pubmed">32269505</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Vandoorne T, Steyaert J, Staats KA, Van Den Bosch L. The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications. Brain. 2020;143(6):1651&#x2013;1673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7296858</ArticleId><ArticleId IdType="pubmed">32206784</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland LG, Sahai E, Kelly G, Golding M, Greensmith L, Schiavo G. Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A. 2010;107(47):20523&#x2013;20528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2996651</ArticleId><ArticleId IdType="pubmed">21059924</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian F, Yang W, Mordes DA, Wang JY, Salameh JS, Mok J, et al. Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging. Nat Commun. 2016;7:13283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5095598</ArticleId><ArticleId IdType="pubmed">27796305</ArticleId></ArticleIdList></Reference><Reference><Citation>Warita H, Itoyama Y, Abe K. Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res. 1999;819(1&#x2013;2):120&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">10082867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieran D, Hafezparast M, Bohnert S, Dick JR, Martin J, Schiavo G, et al. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol. 2005;169(4):561&#x2013;567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2171702</ArticleId><ArticleId IdType="pubmed">15911875</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology. 1996;47(2):535&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">8757033</ArticleId></ArticleIdList></Reference><Reference><Citation>Osking Z, Ayers JI, Hildebrandt R, Skruber K, Brown H, Ryu D, et al. ALS-linked SOD1 mutants enhance neurite outgrowth and branching in adult motor neurons. iScience. 2019;11:294&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6327879</ArticleId><ArticleId IdType="pubmed">30639851</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185(2):232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Encalada SE, Goldstein LS. Biophysical challenges to axonal transport: motor-cargo deficiencies and neurodegeneration. Annu Rev Biophys. 2014;43:141&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">24702007</ArticleId></ArticleIdList></Reference><Reference><Citation>Maday S, Twelvetrees AE, Moughamian AJ, Holzbaur EL. Axonal transport: cargo-specific mechanisms of motility and regulation. Neuron. 2014;84(2):292&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4269290</ArticleId><ArticleId IdType="pubmed">25374356</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirokawa N, Noda Y, Tanaka Y, Niwa S. Kinesin superfamily motor proteins and intracellular transport. Rev Mol Cell Biol. 2009;10(10):682&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">19773780</ArticleId></ArticleIdList></Reference><Reference><Citation>Niwa S, Tanaka Y, Hirokawa N. KIF1Bbeta- and KIF1A-mediated axonal transport of presynaptic regulator Rab3 occurs in a GTP-dependent manner through DENN/MADD. Nat Cell Biol. 2008;10(11):1269&#x2013;1279.</Citation><ArticleIdList><ArticleId IdType="pubmed">18849981</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedes-Dias P, Nirschl JJ, Abreu N, Tokito MK, Janke C, Magiera MM, et al. Kinesin-3 responds to local microtubule dynamics to target synaptic cargo delivery to the presynapse. Curr Biol. 2019;29(2):268&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6342647</ArticleId><ArticleId IdType="pubmed">30612907</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Yamazaki H, Sekine-Aizawa Y, Hirokawa N. The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors. Cell. 1995;81(5):769&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pubmed">7539720</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y, Niwa S, Dong M, Farkhondeh A, Wang L, Zhou R, et al. The molecular motor KIF1A transports the TrkA neurotrophin receptor and is essential for sensory neuron survival and function. Neuron. 2016;90(6):1215&#x2013;1229.</Citation><ArticleIdList><ArticleId IdType="pubmed">27263974</ArticleId></ArticleIdList></Reference><Reference><Citation>Stucchi R, Plucinska G, Hummel JJA, Zahavi EE, Guerra San JI, Klykov O, et al. Regulation of KIF1A-driven dense core vesicle transport: Ca(2+)/CaM controls DCV binding and liprin-alpha/TANC2 recruits DCVs to postsynaptic sites. Cell Rep. 2018;24(3):685&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077247</ArticleId><ArticleId IdType="pubmed">30021165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo KY, Kuzmin A, Unger SM, Petersen JD, Silverman MA. KIF1A is the primary anterograde motor protein required for the axonal transport of dense-core vesicles in cultured hippocampal neurons. Neurosci Lett. 2011;491(3):168&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">21256924</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonekawa Y, Harada A, Okada Y, Funakoshi T, Kanai Y, Takei Y, et al. Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-deficient mice. J Cell Biol. 1998;141(2):431&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2148442</ArticleId><ArticleId IdType="pubmed">9548721</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicita F, Ginevrino M, Travaglini L, D'Arrigo S, Zorzi G, Borgatti R, et al. Heterozygous KIF1A variants underlie a wide spectrum of neurodevelopmental and neurodegenerative disorders. J Med Genet. 2021;58(7):475&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">32737135</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevanin G, Santorelli FM, Azzedine H, Coutinho P, Chomilier J, Denora PS, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet. 2007;39(3):366&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">17322883</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97(6):1268&#x2013;1283.e1266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, Svenson IK, et al. A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10) Am J Hum Genet. 2002;71(5):1189&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC385095</ArticleId><ArticleId IdType="pubmed">12355402</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133(Pt 2):591&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2822627</ArticleId><ArticleId IdType="pubmed">20110243</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, Chia R, Miller DE, Li R, Kumaran R, Abramzon Y, et al. Association of variants in the SPTLC1 gene with juvenile amyotrophic lateral sclerosis. JAMA Neurol. 2021;78:1236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8406220</ArticleId><ArticleId IdType="pubmed">34459874</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohassel P, Donkervoort S, Lone MA, Nalls M, Gable K, Gupta SD, et al. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. Nat Med. 2021;27(7):1197&#x2013;1204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9309980</ArticleId><ArticleId IdType="pubmed">34059824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wvea R. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur J Hum Genet. 2018;26(10):1537&#x2013;1546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6138692</ArticleId><ArticleId IdType="pubmed">29955173</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek RAA, van Rheenen W, Pulit SL, Kenna KP, van den Berg LH, Veldink JH. The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(5&#x2013;6):432&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893599</ArticleId><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347(6229):1436&#x2013;1441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Wang JL, Huang W, Zeng S, Jiao B, Liu Z, et al. Expansion of human-specific GGC repeat in neuronal intranuclear inclusion disease-related disorders. Am J Hum Genet. 2019;105(1):166&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612530</ArticleId><ArticleId IdType="pubmed">31178126</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhao T, Zhang Y, Zhang K, Shi L, Chen Y, et al. Performance evaluation of pathogenicity-computation methods for missense variants. Nucleic Acids Res. 2018;46(15):7793&#x2013;7804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6125674</ArticleId><ArticleId IdType="pubmed">30060008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Yu D, Gu QH, Yang Y, Tu K, Zhu J, et al. miR-191 and miR-135 are required for long-lasting spine remodelling associated with synaptic long-term depression. Nat Commun. 2014;5:3263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3951436</ArticleId><ArticleId IdType="pubmed">24535612</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren M, Hu Z, Chen Q, Jaffe A, Li Y, Sadashivaiah V, et al. KCNH2&#x2013;3.1 mediates aberrant complement activation and impaired hippocampal-medial prefrontal circuitry associated with working memory deficits. Mol Psychiatry. 2020;25(1):206&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">31570775</ArticleId></ArticleIdList></Reference><Reference><Citation>Granseth B, Odermatt B, Royle SJ, Lagnado L. Clathrin-mediated endocytosis is the dominant mechanism of vesicle retrieval at hippocampal synapses. Neuron. 2006;51(6):773&#x2013;786.</Citation><ArticleIdList><ArticleId IdType="pubmed">16982422</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchia SD, Tessa A, Dosi C, Baldacci J, Pasquariello R, Antenora A, et al. Monoallelic KIF1A-related disorders: a multicenter cross sectional study and systematic literature review. J Neurol. 2022;269(1):437&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">34487232</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei L, Laub F, Lush M, Romero M, Zhou J, Luikart B, et al. The zinc finger transcription factor Klf7 is required for TrkA gene expression and development of nociceptive sensory neurons. Genes Dev. 2005;19(11):1354&#x2013;1364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1142558</ArticleId><ArticleId IdType="pubmed">15937222</ArticleId></ArticleIdList></Reference><Reference><Citation>Riviere JB, Ramalingam S, Lavastre V, Shekarabi M, Holbert S, Lafontaine J, et al. KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet. 2011;89(2):219&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3155159</ArticleId><ArticleId IdType="pubmed">21820098</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Ende EL, Jackson JL, White A, Seelaar H, van Blitterswijk M, Van Swieten JC. Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions. J Neurol Neurosurg Psychiatry. 2021;92(5):502&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053328</ArticleId><ArticleId IdType="pubmed">33452054</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi-Fakhari D, Saffari A, Westenberger A, Klein C. The evolving spectrum of PRRT2-associated paroxysmal diseases. Brain. 2015;138(Pt 12):3476&#x2013;3495.</Citation><ArticleIdList><ArticleId IdType="pubmed">26598493</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Yilmaz R, Muller K, Grehl T, Petri S, Meyer T, et al. Hot-spot KIF5A mutations cause familial ALS. Brain. 2018;141(3):688&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837483</ArticleId><ArticleId IdType="pubmed">29342275</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiba K, Takahashi H, Chen M, Obinata H, Arai S, Hashimoto K, et al. Disease-associated mutations hyperactivate KIF1A motility and anterograde axonal transport of synaptic vesicle precursors. Proc Natl Acad Sci U S A. 2019;116(37):18429&#x2013;18434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6744892</ArticleId><ArticleId IdType="pubmed">31455732</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh W, Vale RD. Disease-associated mutations in human BICD2 hyperactivate motility of dynein-dynactin. J Cell Biol. 2017;216(10):3051&#x2013;3060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5626548</ArticleId><ArticleId IdType="pubmed">28883039</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L, Desai J, Miranda CJ, Duncan JS, Qiu W, Nugent AA, et al. Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling. Neuron. 2014;82(2):334&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4002761</ArticleId><ArticleId IdType="pubmed">24656932</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Vaart B, van Riel WE, Doodhi H, Kevenaar JT, Katrukha EA, Gumy L, et al. CFEOM1-associated kinesin KIF21A is a cortical microtubule growth inhibitor. Dev Cell. 2013;27(2):145&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">24120883</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, Bowen S, et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science. 2003;300(5620):808&#x2013;812.</Citation><ArticleIdList><ArticleId IdType="pubmed">12730604</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng W, Garrett C, Dombert B, Soura V, Banks G, Fisher EM, et al. Neurodegenerative mutation in cytoplasmic dynein alters its organization and dynein-dynactin and dynein-kinesin interactions. J Biol Chem. 2010;285(51):39922&#x2013;39934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000974</ArticleId><ArticleId IdType="pubmed">20889981</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron DM, Fenton AR, Saez-Atienzar S, Giampetruzzi A, Sreeram A, et al. ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function. Cell Rep. 2022;39(1):110598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9134378</ArticleId><ArticleId IdType="pubmed">35385738</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo L, Yue Y, Ren J, Yu J, Liu J, Yu Y, et al. The CC1-FHA tandem as a central hub for controlling the dimerization and activation of kinesin-3 KIF1A. Structure. 2012;20(9):1550&#x2013;1561.</Citation><ArticleIdList><ArticleId IdType="pubmed">22863567</ArticleId></ArticleIdList></Reference><Reference><Citation>Niwa S, Lipton DM, Morikawa M, Zhao C, Hirokawa N, Lu H, et al. Autoinhibition of a neuronal kinesin UNC-104/KIF1A regulates the size and density of synapses. Cell Rep. 2016;16(8):2129&#x2013;2141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5432123</ArticleId><ArticleId IdType="pubmed">27524618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel JJA, Hoogenraad CC. Specific KIF1A-adaptor interactions control selective cargo recognition. J Cell Biol. 2021;220(10):e202105011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298099</ArticleId><ArticleId IdType="pubmed">34287616</ArticleId></ArticleIdList></Reference><Reference><Citation>Soppina V, Norris SR, Dizaji AS, Kortus M, Veatch S, Peckham M, et al. Dimerization of mammalian kinesin-3 motors results in superprocessive motion. Proc Natl Acad Sci U S A. 2014;111(15):5562&#x2013;5567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3992690</ArticleId><ArticleId IdType="pubmed">24706892</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond JW, Cai D, Blasius TL, Li Z, Jiang Y, Jih GT, et al. Mammalian Kinesin-3 motors are dimeric in vivo and move by processive motility upon release of autoinhibition. PLoS Biol. 2009;7(3):e72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2661964</ArticleId><ArticleId IdType="pubmed">19338388</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>